Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
1.910
+0.110 (6.11%)
At close: Aug 13, 2025, 4:00 PM
1.930
+0.020 (1.05%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
Precigen Employees
Precigen had 143 employees as of December 31, 2024. The number of employees decreased by 59 or -29.21% compared to the previous year.
Employees
143
Change (1Y)
-59
Growth (1Y)
-29.21%
Revenue / Employee
$30,350
Profits / Employee
-$870,629
Market Cap
569.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PGEN News
- 5 weeks ago - Precigen: August Is Pivotal For This Biotech Innovator - Seeking Alpha
- 3 months ago - Precigen Reports First Quarter 2025 Financial Results and Business Updates - PRNewsWire
- 4 months ago - Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th - PRNewsWire
- 5 months ago - Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Precigen Reports Full Year 2024 Financial Results and Business Updates - PRNewsWire
- 5 months ago - Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th - PRNewsWire
- 5 months ago - Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement - Seeking Alpha
- 6 months ago - FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 - PRNewsWire